Animal Vaccines Market by Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, DNA Vaccines) and Animal type (Companion Animal, Livestock Animal and Aquaculture): Global Opportunity Analysis and Industry Forecast, 2021–2028
- ALL4621640
- 210 Pages
- May 2021
- Medical Devices
The global animal vaccines market was valued at $9,093.9 million in 2020, and is projected to reach $13,780.6 million by 2028, registering a CAGR of 5.3% from 2021 to 2028. The market is expected to witness moderate growth during the forecast period, owing to the increase in adoption of companion animal worldwide and rise in the awareness about animal health with respect to livestock and pet animal. In addition, increase in meat and milk consumption and rise in the emergence of zoonotic diseases supplement the animal vaccines market growth. However, high cost of vaccine production and storage and unnecessary excessive vaccine administration to animal hamper the market growth. Moreover, lack of awareness regarding animal welfare among pet owners hinders the expansion of the animal vaccines market.
The animal vaccines market is segmented on the basis of product type, animal type, and region. By product type, the market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. By animal type, the market is segmented into companion animal, livestock animal, and aquaculture. The companion animal segment is further segmented into cats and dogs. The livestock animal segment is further classified into cattle, pigs, poultry, sheep, and others (goats, horses, asses, camel, and others). By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis along with the current global animal vaccines market trends from 2020 to 2028 to identify the prevailing opportunities along with the strategic assessment.
The global animal vaccines market forecast is studied from 2021 to 2028.
The animal vaccines market size and estimations are based on a comprehensive analysis of key developments in the industry.
A qualitative analysis based on innovative products facilitates strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global animal vaccines market.
KEY MARKET SEGMENTS
By Type
• Attenuated Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Conjugate Vaccines
• Recombinant Vaccines
• DNA Vaccines
By Animal Type
• Companion animal
o Dogs
o Cats
• Livestock animal
o Cattle
o Pigs
o Poultry
o Sheep
o Others
• Aquaculture
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Rest of Europe
o Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
Rest of LAMEA
KEY MARKET PLAYERS
• Merck & Co.
• Zoetis Inc.
• Ceva Santé Animale
• Sanofi S.A.
• Romvac
• Vaxxinova GmbH
• Biovac
• Anicon Labor GmbH
• Merial
• Boehringer Ingelheim Gmb
1.1.Report description
1.2.Key benefits to the stakeholders
1.3.Key market segments
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top winning strategies
3.2.2.Top investment pockets
3.3.Government Regulations
3.3.1.Center for Veterinary Biologics (CVB)
3.4.Top player positioning
3.5.Porter’s five forces analysis
3.6.Market dynamics
3.6.1.Drivers
3.6.1.1.Growth in demand for pet insurance
3.6.1.2.Increase in prevalence of animal diseases
3.6.1.3.Growth in ownership of companion animal
3.6.1.4.Rise in animal health expenditure
3.6.2.Restraints
3.6.2.1.Highly competitive meat and milk prices
3.6.2.2.Adverse impact of veterinary vaccines on human and animal health
3.6.3.Opportunities
3.6.3.1.Advancement in vaccine products
3.6.3.2.Increase in demand for hybrid animal
CHAPTER 4:ANIMAL VACCINES MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Attenuated Vaccines
4.2.1.Key market trends, key growth factors and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Inactivated Vaccines
4.3.1.Key market trends, key growth factors and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Subunit Vaccines
4.4.1.Key market trends, key growth factors and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.5.Toxoid Vaccines
4.5.1.Key market trends, key growth factors and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country
4.6.Conjugate Vaccines
4.6.1.Key market trends, key growth factors and opportunities
4.6.2.Market size and forecast
4.6.3.Market analysis, by country
4.7.Recombinant Vaccines
4.7.1.Key market trends, key growth factors and opportunities
4.7.2.Market size and forecast
4.7.3.Market analysis, by country
4.8.DNA Vaccines
4.8.1.Key market trends, key growth factors and opportunities
4.8.2.Market size and forecast
4.8.3.Market analysis, by country
CHAPTER 5:ANIMAL VACCINES MARKET, BY ANIMAL TYPE
5.1.Overview
5.1.1.Market size and forecast
5.2.Companion animal
5.2.1.Market size and forecast, by type
5.2.1.1.Dogs
5.2.1.1.1.Market size and forecast
5.2.1.2.Cats
5.2.1.2.1.Market size and forecast
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Livestock Animal
5.3.1.1.Cattle
5.3.1.1.1.Market size and forecast
5.3.1.2.Pigs
5.3.1.2.1.Market size and forecast
5.3.1.3.Poultry
5.3.1.3.1.Market size and forecast
5.3.1.4.Sheep
5.3.1.4.1.Market size and forecast
5.3.1.5.Others
5.3.1.5.1.Market size and forecast
5.3.2.Market size and forecast
5.3.3.Market analysis, by country
5.4.Aquaculture
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
CHAPTER 6:ANIMAL VACCINES MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends
6.2.2.Key growth factors and opportunities
6.2.3.Market size and forecast, by product
6.2.4.Market size and forecast, by animal type
6.2.5.Market size and forecast, by country
6.2.5.1.U.S. market size and forecast, by product
6.2.5.2.U.S. market size and forecast, by animal type
6.2.5.3.Canada market size and forecast, by product
6.2.5.4.Canada market size and forecast, by animal type
6.2.5.5.Mexico market size and forecast, by product
6.2.5.6.Mexico market size and forecast, by animal type
6.3.Europe
6.3.1.Key market trends
6.3.2.Key growth factors and opportunities
6.3.3.Market size and forecast, by product
6.3.4.Market size and forecast, by animal type
6.3.5.Market size and forecast, by country
6.3.5.1.Germany market size and forecast, by product
6.3.5.2.Germany market size and forecast, by animal type
6.3.5.3.France market size and forecast, by product
6.3.5.4.France market size and forecast, by animal type
6.3.5.5.UK market size and forecast, by product
6.3.5.6.UK market size and forecast, by animal type
6.3.5.7.Italy market size and forecast, by product
6.3.5.8.Italy market size and forecast, by animal type
6.3.5.9.Rest of Europe market size and forecast, by product
6.3.5.10.Rest of Europe market size and forecast, by animal type
6.4.Asia-Pacific
6.4.1.Key market trends
6.4.2.Key growth factors and opportunities
6.4.3.Market size and forecast, by product
6.4.4.Market size and forecast, by animal type
6.4.5.Market size and forecast, by country
6.4.5.1.Japan market size and forecast, by product
6.4.5.2.Japan market size and forecast, by animal type
6.4.5.3.China market size and forecast, by product
6.4.5.4.China market size and forecast, by animal type
6.4.5.5.Australia market size and forecast, by product
6.4.5.6.Australia market size and forecast, by animal type
6.4.5.7.India market size and forecast, by product
6.4.5.8.India market size and forecast, by animal type
6.4.5.9.South Korea market size and forecast, by product
6.4.5.10.South Korea market size and forecast, by animal type
6.4.5.11.Rest of Asia-Pacific market size and forecast, by product
6.4.5.12.Rest of Asia-Pacific market size and forecast, by animal type
6.5.LAMEA
6.5.1.Key market trends
6.5.2.Key growth factors and opportunities
6.5.3.Market size and forecast, by product
6.5.4.Market size and forecast, by animal type
6.5.5.Market size and forecast, by country
6.5.5.1.Brazil market size and forecast, by product
6.5.5.2.Brazil market size and forecast, by animal type
6.5.5.3.Saudi Arabia market size and forecast, by product
6.5.5.4.Saudi Arabia market size and forecast, by animal type
6.5.5.5.Rest of LAMEA market size and forecast, by product
6.5.5.6.Rest of LAMEA market size and forecast, by animal type
CHAPTER 7:COMPANY PROFILES
7.1.Anicon Labor GmbH
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.2.Boehringer Ingelheim GmbH
7.2.1.Company overview
7.2.2.Operating business segments
7.2.3.Business performance
7.3.Ceva Santé Animale
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Product portfolio
7.3.4.Business performance
7.3.5.Key strategic moves & developments
7.4.Hygieia Biological Laboratories
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.5.Merck & company Inc.
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.Romvac company S.A.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.7.Sanofi S.A.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments
7.8.Vaxxinova Gmbh-Germany
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Key strategic moves and developments
7.9.Virbac S.A
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.10.Zoetis Inc.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves & developments
TABLE 01.NUMBER OF U.S. HOUSEHOLDS THAT OWN A PET, BY TYPE OF ANIMAL (MILLION)
TABLE 02.POPULATION OF DOGS AND CATS IN EUROPEAN COUNTRIES, 2019
TABLE 03.GLOBAL ANIMAL VACCINES MARKET, BY PRODUCT TYPE 2020-2028, ($MILLION)
TABLE 04.ATTENUATED ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 05.INACTIVATED ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 06.SUBUNIT ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 07.TOXOID ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 08.CONJUGATE ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 09.RECOMBINANT ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 10.DNA ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 11.GLOBAL ANIMAL VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 12.COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2028, ($MILLION)
TABLE 13.COMPANION ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 14.ANIMAL VACCINES MARKET FOR LIVESTOCK, BY REGION, 2020-2028, ($MILLION)
TABLE 15.ANIMAL VACCINES MARKET FOR AQUACULTURE, BY REGION, 2020-2028, ($MILLION)
TABLE 16.ANIMAL VACCINES MARKET, BY GEOGRAPHY 2020-2028, ($MILLION)
TABLE 17.NORTH AMERICA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 18.NORTH AMERICA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 19.NORTH AMERICA ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2028, ($MILLION)
TABLE 20.U.S. ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 21.U.S. VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 22.CANADA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 23.CANADA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 24.MEXICO ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 25.MEXICO VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 26.EUROPE ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 27.EUROPE VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 28.EUROPE ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2028, ($MILLION)
TABLE 29.GERMANY ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 30.GERMANY VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 31.FRANCE ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 32.FRANCE VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 33.UK ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 34.UK VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 35.ITALY ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 36.ITALY VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 37.REST OF EUROPE ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 38.REST OF EUROPE VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 39.ASIA-PACIFIC ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 40.ASIA-PACIFIC VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 41.ASIA-PACIFIC ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2028, ($MILLION)
TABLE 42.JAPAN ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 43.JAPAN VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 44.CHINA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 45.CHINA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 46.AUSTRALIA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 47.AUSTRALIA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 48.INDIA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 49.INDIA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 50.SOUTH KOREA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 51.SOUTH KOREA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 52.REST OF ASIA-PACIFIC ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 53.REST OF ASIA-PACIFIC VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 54.LAMEA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 55.LAMEA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 56.LAMEA ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2028, ($MILLION)
TABLE 57.BRAZIL ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 58.BRAZIL VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 59.SAUDI ARABIA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 60.SAUDI ARABIA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 61.REST OF LAMEA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 62.REST OF LAMEA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 63.ANICON: COMPANY SNAPSHOT
TABLE 64.ANICON: OPERATING SEGMENTS
TABLE 65.ANICON: PRODUCT PORTFOLIO
TABLE 66.BOEHRINGER: COMPANY SNAPSHOT
TABLE 67.BOEHRINGER: OPERATING SEGMENTS
TABLE 68.CEVA: COMPANY SNAPSHOT
TABLE 69.CEVA: PRODUCT PORTFOLIO
TABLE 70.HYGIEIA: COMPANY SNAPSHOT
TABLE 71.HYGIEIA: OPERATING SEGMENTS:
TABLE 72.HYGIEIA: PRODUCT PORTFOLIO
TABLE 73.MERCK: COMPANY SNAPSHOT
TABLE 74.MERCK: OPERATING SEGMENTS
TABLE 75.MERCK: PRODUCT PORTFOLIO
TABLE 76.ROMVAC: COMPANY SNAPSHOT
TABLE 77.ROMVAC: OPERATING SEGMENTS
TABLE 78.ROMVAC: PRODUCT PORTFOLIO
TABLE 79.SANOFI: COMPANY SNAPSHOT
TABLE 80.SANOFI: OPERATING SEGMENTS
TABLE 81.SANOFI: PRODUCT PORTFOLIO
TABLE 82.VAXXINOVA: COMPANY SNAPSHOT
TABLE 83.VAXXINOVA: OPERATING SEGMENTS
TABLE 84.VAXXINOVA: PRODUCT PORTFOLIO
TABLE 85.VIRBAC: COMPANY SNAPSHOT
TABLE 86.VIRBAC: OPERATING SEGMENTS
TABLE 87.VIRBAC: PRODUCT PORTFOLIO
TABLE 88.ZOETIS: COMPANY SNAPSHOT
TABLE 89.ZOETIS: OPERATING SEGMENTS
TABLE 90.ZOETIS: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
